[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [HEALTH]

33 clusters · 253 sources · 126 days · First seen · Last updated

Brazil ANVISA expands product safety enforcement

Overview

Since May 2026, Brazil’s National Health Surveillance Agency (ANVISA) has intensified enforcement of sanitary rules for pharmaceuticals, cosmetics, and consumer goods. Early actions included suspending batches of statins, dexamethasone, enalapril, and the oncology drug Halaven; recalling infant formula, injectable antibiotics, and saline solution due to contamination or quality defects. In June, the agency prohibited unregistered herbal drugs, banned formaldehyde and glioxilic acid in hair-straightening products, and seized illegal e-cigarettes. ANVISA also suspended the Voy obesity-treatment platform and recalled various supplements. Regulatory focus expanded to include medical supply storage standards and new cosmetic ingredient restrictions. Throughout July, enforcement targeted contaminated mineral water, energy drinks, and illegal weight-loss pens containing the experimental drug retatrutida. In August, enforcement expanded significantly. ANVISA prohibited six salt products from Quanqton for clandestine manufacturing and deceptive health claims, and banned 12 cleaning products—including brands such as Oxypur and Yta Clean—due to a lack of sanitary regulation. The agency also targeted unregistered weight-loss products, including Chá Sarapião by Natural Ervas Produtos Naturais Ltda. (Farmagon) and various items marketed as Milagroso Ervas or Mounfor X Emagrecedor, prompting PROCON/SC to monitor markets. Additionally, dietary supplements from Newfit and SharkPro were banned; laboratory analysis found Newfit products contained undeclared substances like sibutramine, fluoxetine, and furosemide, while SharkPro faced recalls due to manufacturing violations. Parallel to these actions, Brazil has seen a surge in the importation and smuggling of weight-loss medications, specifically GLP-1 agonists like semaglutide and tirzepatide. Official data shows imports grew by 85% in the first seven months of 2026, reaching US$ 1.512 billion. The value of seized weight-loss pens by the Federal Revenue rose from R$ 4 million in early 2025 to over R$ 80 million in the first half of 2026.

Entities

Anvisa · Brazil · Paraguay · Agência Nacional de Vigilância Sanitária (Anvisa) · Receita Federal

Claims

What the coverage asserts, and how many sources carry each claim.

Timeline

  1. 3 days ago

    [CRIME] 27 sources
    Anvisa seizes falsified cancer drug Phesgo and Dysport batches

    Anvisa has seized falsified batches of cancer drug Phesgo and Dysport, while police investigate a criminal network of doctors and officials for fraud in high-cost medication procurement across Brazil.

  2. 8 days ago

    [HEALTH] 29 sources
    Anvisa bans Paraguayan T36 weight-loss medication in Brazil

    Anvisa has banned the import, sale, and use of T36, a Paraguayan-made tirzepatide weight-loss medication, due to a lack of sanitary registration and safety evaluations in Brazil.

  3. 14 days ago

    [HEALTH] 4 sources
    Brazil combats illegal weight-loss drug market as Anvisa fast-tracks generics

    Brazil faces a surge in illegal weight-loss drug smuggling from Paraguay while Anvisa implements new rules to accelerate the registration of generic semaglutide competitors.

  4. 22 days ago

    [CRIME] 2 sources
    Brazil authorities seize drugs and illegal weight loss medications

    Brazilian authorities seized 130kg of marijuana and over 1,500 ampoules of prohibited weight loss medication in recent operations targeting smuggling from Paraguay.

  5. 23 days ago

    [HEALTH] 49 sources
    Anvisa seizes United Labz products and suspends Unilever production

    Anvisa has ordered the seizure of United Labz weight-loss products and suspended Unilever's cleaning product manufacturing in Vinhedo due to regulatory failures.

  6. 27 days ago

    [HEALTH] 13 sources
    Anvisa updates quality control rules for Brazilian laboratories

    Anvisa has updated regulations for public and private laboratories in Brazil, requiring adherence to ISO/IEC 17025 standards and stricter biosafety protocols to enhance product quality control.

  7. 27 days ago

    [BUSINESS] 2 sources
    Brazil weight loss pen seizures surge 20-fold to R$ 80 million

    Seizures of unauthorized weight loss pens in Brazil rose from R$ 4 million to over R$ 80 million in the first half of 2026, driven by smuggling from Paraguay and illegal online sales.

  8. about 1 month ago

    [HEALTH] 11 sources
    Anvisa bans Newfit and Shark Pro supplements over irregularities

    Anvisa has banned the sale and manufacture of Newfit and Shark Pro supplements due to adulteration with undeclared drugs and severe manufacturing failures in Brazil.

  9. about 1 month ago

    [HEALTH] 12 sources
    Anvisa bans unregistered weight-loss teas and capsules in Brazil

    Anvisa has banned the sale and use of several unregistered weight-loss teas and capsules in Brazil, including Chá Sarapião and various ‘Milagroso Ervas’ products, due to lack of sanitary authorization.

  10. about 1 month ago

    [HEALTH] 17 sources
    Anvisa bans 12 cleaning products for lack of sanitary regulation

    Anvisa has banned the sale, manufacture, and use of 12 cleaning products in Brazil, including various bleaches and stain removers, due to a lack of sanitary registration and company authorization.

  11. about 1 month ago

    [HEALTH] 15 sources
    Brazil weight-loss drug imports surge 85% amid smuggling rise

    Brazil sees an 85% rise in weight-loss drug imports and a surge in smuggled pens from Paraguay, prompting the Federal Council of Medicine to warn doctors against prescribing unauthorized medications.

  12. about 2 months ago

    [HEALTH] 13 sources
    Anvisa bans six types of unregulated salt products in Brazil

    Anvisa has banned and ordered the seizure of six unregulated salt products from the brand Quanqton in Brazil due to clandestine manufacturing and deceptive health claims.

  13. about 2 months ago

    [HEALTH] 15 sources
    Brazil's Anvisa suspends multiple medical and consumer products over safety concerns

    Anvisa has suspended or recalled dozens of medical, pharmaceutical, food and cosmetic products in Brazil over safety and regulatory violations, affecting manufacturers and consumers nationwide.

  14. about 2 months ago

    [HEALTH] 55 sources
    Brazil's Anvisa orders recall of Paramol batch and seizes counterfeit Mounjaro

    Anvisa recalled a mold‑contaminated Paramol batch and seized counterfeit Mounjaro units with an illegal serial number, urging consumers to stop use and verify authenticity.

  15. about 2 months ago

    [HEALTH] 2 sources
    Brazil's Anvisa warns that counterfeit weight‑loss injection pens threaten heart health

    Brazil's Anvisa warns that fake weight‑loss injection pens sold online can cause arrhythmias and heart attacks, urging consumers to avoid unregistered products.

  16. about 2 months ago

    [HEALTH] 4 sources
    Retatrutida remains unapproved as Brazil seizes over R$11 million of illegal shipments

    Retatrutida, an unapproved experimental obesity drug, was seized by Brazilian authorities in illegal shipments from Paraguay worth over R$11 million in early 2026, highlighting health risks and lack of approval

  17. 2 months ago

    [HEALTH] 14 sources
    Brazil's Anvisa warns against illegal retatrutida weight‑loss pens

    Anvisa warns that experimental obesity drug retatrutida, still unapproved worldwide, is being sold illegally in Brazil, with seizures exceeding R$ 11 million in early 2026 and serious health risks.

  18. 2 months ago

    [HEALTH] 37 sources
    Brazil's Anvisa recalls Mamba Water batches over contamination

    Brazil's health regulator Anvisa recalled Mamba Water cans (lots 13‑14) after detecting Pseudomonas aeruginosa and suspended all Mister Hemp energy drinks over safety and registration failures.

  19. 3 months ago

    [HEALTH] 2 sources
    Brazil's ANVISA issues new rules on cosmetic ingredient restrictions

    ANVISA released new resolutions restricting and prohibiting certain cosmetic ingredients, opened a public consultation for further restrictions, and continues its broader role regulating health‑related products

  20. 3 months ago

    [HEALTH] 2 sources
    Brazil's Anvisa suspends Dobutamine drug and bans products from five firms

    Anvisa has suspended the dobutamine drug over quality concerns and banned supplements from five firms for safety and registration violations.

  21. 3 months ago

    [HEALTH] 2 sources
    Brazil's Anvisa orders recall of repellent batch and several cosmetics

    Anvisa in Brazil has recalled a repellent batch that failed IR3535 efficacy tests and suspended several DC Biocosméticos cosmetics and all products bearing ATSUM’s label for lacking proper sanitary registration

  22. 3 months ago

    [HEALTH] 11 sources
    Brazil's Anvisa bans digital health platform, recalls repellent, cosmetics and industrial kerosene

    Anvisa shut down the Voy telehealth platform, recalled a faulty Repele repellent batch, blocked unregistered DC Biocosméticos cosmetics, and ordered a nationwide recall of Querosene Petrus cleaning product.

  23. 3 months ago

    [HEALTH] 2 sources
    Anvisa seizes Artro100 supplement and recalls creatine gum batches

    Anvisa seized the Artro100 supplement and recalled Idn Labs' creatine‑gum batches (lots 0061/02/2026, 0367/11/2025, 0012/01/2026) due to composition, labeling and unauthorized health‑claim issues.

  24. 3 months ago

    [HEALTH] 8 sources
    Anvisa bans Voy weight‑loss platform for lacking medical‑software registration

    Anvisa prohibited the Voy obesity‑treatment platform for missing medical‑software registration and pharmacy authorization, warning of unsafe drug sourcing; Voy says it will stay online pending appeal.

  25. 3 months ago

    [HEALTH] 36 sources
    Anvisa bans obesity‑treatment platform Voy and suspends Artro100 supplement and creatine gummies

    Anvisa suspended the Voy obesity‑treatment platform for lacking medical‑device registration and banned the Artro100 supplement and certain creatine‑gum batches due to unknown composition, illegal health claims,

  26. 3 months ago

    [HEALTH] 3 sources
    Brazil's Anvisa Tightens Hair‑Straightening Product Rules

    Anvisa bans formaldehyde and glioxilic acid in hair‑straightening products, enforces registration, and highlights health risks, while France urges EU limits on Brazilian‑style straighteners.

  27. 3 months ago

    [HEALTH] 8 sources
    Anvisa seizes over 25,000 illegal electronic cigarettes in Brazil

    Anvisa and Receita Federal seized over 25,000 illegal e‑cigarettes and 107,000 contraband cigarette packs nationwide, citing health risks to youth and enforcing the ban under RDC 855/2024.

  28. 3 months ago

    [HEALTH] 4 sources
    Brazilian health agencies urge clinics to tighten medical supply storage

    Brazil’s growing medical‑product market is prompting Anvisa and experts to push clinics for better temperature, humidity and documentation controls to keep supplies safe.

  29. 3 months ago

    [HEALTH] 19 sources
    Brazil's Anvisa recalls antibiotics and saline solution over quality defects

    Anvisa recalled two antibiotics—Polycid with a glass fragment and clindamycin with discoloration/particles—and a saline solution due to quality deviations, urging immediate removal from use.

  30. 4 months ago

    [HEALTH] 2 sources
    Brazil's Anvisa orders recall of Essentia Pharma infant formula

    Anvisa ordered a nationwide recall of Essentia Pharma infant formula made by HKM Farmácia, citing lack of registration and misleading labels that could endanger infants.

  31. 4 months ago

    [HEALTH] 2 sources
    Brazil's Anvisa extends digital prescription deadline and bans three consumer products

    Anvisa delayed its digital prescription system to Sept 30 2026 and banned a Colgate toothbrush, a Sócio Rico perfume and a sodium percarbonate bleach over registration issues.

  32. 4 months ago

    [HEALTH] 2 sources
    Brazil's Anvisa suspends medication lots, seizes cosmetics

    Anvisa halted specific hypertension and breast‑cancer drug batches for quality issues and ordered the seizure of unregistered cosmetics, banning their sale and use in Brazil.

  33. 4 months ago

    [HEALTH] 8 sources
    Brazil's Anvisa suspends specific statin and dexamethasone batches

    Anvisa halts specific statin and dexamethasone batches over packaging mix‑up and solution issues, also bans unregistered herbal medicines.

Sources

98fmnatal.com.br · abradilan.com.br · ac24horas.com · acapa.com.br · accessnews.com · acessa.com · acordacidade.com.br · actu.capital.fr · acusticafm.com.br · agenciasertao.com · agorarn.com.br · almasipatika.hu · amp.bemparana.com.br · api.metro1.com.br · aquiacontece.com.br · aquiagora.net · araguaiabrusque.com.br · areavip.com.br · aredacao.com.br · arroyodiario.com.ar · atarde.com.br · atibaia.com.br · atibaiasp.com.br · atualidadepolitica.com.br · bahianoticias.com.br · bahiaprime.com.br · ballstriking.com · bandab.com.br · barulhocuritiba.bemparana.com.br · bemparana.com.br · biathlon-news.de · blogdobg.com.br · blogdomarioadolfo.com.br · bpmoney.com.br · brasil.estadao.com.br · brasil247.com · brasilemfolhas.com · brasilemfolhas.com.br · bsbtimes.com.br · capitalnews.com.br · cardinot.com.br · caririceara.com · cartacapital.com.br · cartaeducacao.com.br · catracalivre.com.br · caue75.fr · cenariomt.com.br · ceskeinvestice.cz

This summary has been updated 16 times: see revision history